Megalin is downregulated via LPS-TNF-α-ERK1/2 signaling pathway in proximal tubule cells
Related Experiment Video
Updated: Jun 3, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Aya Takeyama1, Hiroyoshi Sato, Taeko Soma-Nagae
1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Abstract:
Expression and function of megalin, an endocytic receptor in proximal tubule cells (PTCs), are reduced in diabetic nephropathy, involved in the development of proteinuria/albuminuria. Lipopolysaccharide (LPS) is chronically increased in diabetic sera, by the mechanism called metabolic endotoxemia. We investigated low-level LPS-mediated signaling that regulates megalin expression in immortalized rat PTCs (IRPTCs). Incubation of the cells with LPS (10 ng/ml) for 48 h suppressed megalin protein expression and its endocytic function. TNF-α mRNA expression was increased by LPS treatment, and knockdown of the mRNA with siRNA inhibited LPS-mediated downregulation of megalin mRNA expression at the 24-h time point. Incubation of IRPTCs with exogenous TNF-α also suppressed megalin mRNA and protein expression at the 24- and 48-h time points, respectively. MEK1 inhibitor PD98059 competed partially but significantly TNF-α-mediated downregulation of megalin mRNA expression. Collectively, low-level LPS-mediated TNF-α-ERK1/2 signaling pathway is involved in downregulation of megalin expression in IRPTCs.
Insights
Low-level lipopolysaccharide (LPS) signaling reduces megalin expression in kidney cells via TNF-α and ERK1/2 pathways. This finding is crucial for understanding diabetic nephropathy and proteinuria development.
Area of Science:
- Nephrology
- Molecular Biology
- Endocrinology
Background:
- Diabetic nephropathy is characterized by reduced megalin expression and function in proximal tubule cells (PTCs), contributing to proteinuria.
- Metabolic endotoxemia, indicated by elevated serum lipopolysaccharide (LPS), is a common feature in diabetes.
Purpose of the Study:
- To investigate the mechanisms by which low-level LPS signaling regulates megalin expression in immortalized rat PTCs (IRPTCs).
- To elucidate the role of tumor necrosis factor-alpha (TNF-α) and the ERK1/2 pathway in LPS-induced changes in megalin.
Main Methods:
- IRPTCs were treated with LPS (10 ng/ml) for 48 hours to assess megalin expression and function.
- Tumor necrosis factor-alpha (TNF-α) mRNA was targeted using siRNA, and cells were treated with exogenous TNF-α.
- The MEK1 inhibitor PD98059 was used to assess the involvement of the ERK1/2 pathway.
Main Results:
- LPS treatment significantly suppressed megalin protein expression and endocytic function in IRPTCs.
- LPS increased TNF-α mRNA expression, and its knockdown partially reversed the downregulation of megalin mRNA.
- Exogenous TNF-α mimicked LPS effects, suppressing megalin mRNA and protein, an effect partially inhibited by PD98059.
Conclusions:
- Low-level LPS-mediated signaling, involving TNF-α and the ERK1/2 pathway, downregulates megalin expression in proximal tubule cells.
- These findings offer insights into the molecular mechanisms linking metabolic endotoxemia to kidney dysfunction in diabetic nephropathy.
More Related Videos
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Formation of Lipopolysaccharides
Amplifying Signals via Enzymatic Cascade